DK1024794T3 - Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer - Google Patents

Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer

Info

Publication number
DK1024794T3
DK1024794T3 DK98952043T DK98952043T DK1024794T3 DK 1024794 T3 DK1024794 T3 DK 1024794T3 DK 98952043 T DK98952043 T DK 98952043T DK 98952043 T DK98952043 T DK 98952043T DK 1024794 T3 DK1024794 T3 DK 1024794T3
Authority
DK
Denmark
Prior art keywords
dry
pharmaceutical formulations
capsules
treatment
powdered pharmaceutical
Prior art date
Application number
DK98952043T
Other languages
Danish (da)
English (en)
Inventor
Steven T Horhota
Saim Said
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26741866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1024794(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1024794T3 publication Critical patent/DK1024794T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883Capsule finishing, e.g. dyeing, aromatising, polishing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/02Solvent extraction of solids
    • B01D11/0203Solvent extraction of solids with a supercritical fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00Ancillary equipment
    • A61M2209/02Equipment for testing the apparatus

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98952043T 1997-10-14 1998-10-05 Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer DK1024794T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6209997P 1997-10-14 1997-10-14
US09/157,267 US6228394B1 (en) 1997-10-14 1998-09-21 Supercritical fluid extraction of mould lubricant from hard shell capsules
PCT/US1998/020815 WO1999018939A1 (en) 1997-10-14 1998-10-05 Methods of treating capsules and dry, powdered pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DK1024794T3 true DK1024794T3 (da) 2007-04-10

Family

ID=26741866

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98952043T DK1024794T3 (da) 1997-10-14 1998-10-05 Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer

Country Status (23)

Country Link
US (1) US6228394B1 (xx)
EP (1) EP1024794B1 (xx)
JP (1) JP2001519380A (xx)
KR (1) KR20010031097A (xx)
CN (1) CN1306420A (xx)
AT (1) ATE350019T1 (xx)
AU (1) AU753076B2 (xx)
BG (1) BG65169B1 (xx)
BR (1) BR9814818A (xx)
CA (1) CA2302276C (xx)
CY (1) CY1106033T1 (xx)
CZ (1) CZ299101B6 (xx)
DE (1) DE69836822T2 (xx)
DK (1) DK1024794T3 (xx)
EE (1) EE200000292A (xx)
ES (1) ES2281141T3 (xx)
HU (1) HUP0003990A3 (xx)
IL (1) IL134731A0 (xx)
NZ (1) NZ504394A (xx)
PL (1) PL195462B1 (xx)
PT (1) PT1024794E (xx)
TR (1) TR200001000T2 (xx)
WO (1) WO1999018939A1 (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294194B1 (en) * 1997-10-14 2001-09-25 Boehringer Ingelheim Pharmaceuticals, Inc. Method for extraction and reaction using supercritical fluids
GB9804379D0 (en) * 1998-03-02 1998-04-22 Bradford Particle Design Ltd Method of particle formation
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP1430887A1 (de) * 2000-10-12 2004-06-23 Boehringer Ingelheim Pharma GmbH & Co.KG Tiotropium-haltige Inhalationspulver
US6544282B1 (en) 2001-02-21 2003-04-08 Radiant Medical, Inc. Inhibition of platelet activation, aggregation and/or adhesion by hypothermia
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
ES2300568T3 (es) 2002-03-20 2008-06-16 Mannkind Corporation Aparato de inhalacion.
US20030181749A1 (en) * 2002-03-21 2003-09-25 Kunzler Jay F. Supercritical fluid extraction of vitreoretinal silicone tamponades
EP1504040A1 (en) * 2002-04-23 2005-02-09 Boehringer Ingelheim Pharmaceuticals Inc. Method for reduction of residual organic solvent in carbomer
EP1501479A1 (en) * 2002-05-07 2005-02-02 Nektar Therapeutics Capsules for dry powder inhalers and methods of making and using same
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
WO2005018410A1 (de) * 2003-07-30 2005-03-03 BSH Bosch und Siemens Hausgeräte GmbH Verfahren zum betreiben eines gerätes mit wenigstens einem teilprogrammschritt 'trocknen'
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
BR122019022692B1 (pt) 2004-08-23 2023-01-10 Mannkind Corporation Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
DE102004060479A1 (de) * 2004-12-16 2006-06-29 Schaeffler Kg Verfahren und Vorrichtung zum Schmieren und Kühlen eines hochbelasteten Lagers
US20090107495A1 (en) * 2005-07-21 2009-04-30 National Institute For Materials Science Device for inhalation of medicine
HUE028691T2 (en) 2005-09-14 2016-12-28 Mannkind Corp A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
AR072114A1 (es) 2008-06-13 2010-08-04 Mannkind Corp Un inhalador de polvo seco y sistema para suministro de farmacos
BRPI0914308B8 (pt) 2008-06-20 2021-06-22 Mannkind Corp sistema de inalação
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) * 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
KR101875969B1 (ko) 2009-06-12 2018-07-06 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
RU2571331C1 (ru) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
JP6133270B2 (ja) 2011-04-01 2017-05-24 マンカインド コーポレイション 薬剤カートリッジのためのブリスター包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
JP6018640B2 (ja) 2011-10-24 2016-11-02 マンカインド コーポレイション 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
WO2014144895A1 (en) 2013-03-15 2014-09-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
AU2014290438B2 (en) 2013-07-18 2019-11-07 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
WO2015021064A1 (en) 2013-08-05 2015-02-12 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN108451920A (zh) * 2018-03-14 2018-08-28 绍兴康可胶囊有限公司 一种吸雾式胶囊及其制备方法
CN109289249A (zh) * 2018-12-08 2019-02-01 内蒙合成化工研究所 一种高能推进剂中增塑剂和安定剂的回收方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61155265A (ja) 1984-12-26 1986-07-14 住友重機械工業株式会社 超臨界流体により成形体中のバインダ−を除去する方法
JPH0363232A (ja) 1989-07-10 1991-03-19 Syntex Usa Inc 溶剤抽出方法
DE69019257T2 (de) 1989-07-31 1995-09-28 Ciba Geigy Ag Extraktion organischer Lösungsmittel aus geformten Stoffen durch überkritische Fluide und Gase, nahe am kritischen Punkt.
US5254335A (en) * 1990-10-10 1993-10-19 Clairol Incorporated Hair conditioning compounds containing reactive nonionic surfactants and isothiuronium compounds and method of use
US5198115A (en) * 1991-07-09 1993-03-30 Analytical Bio-Chemistry Laboratories, Inc. Integrated instrument for supercritical fluid sample extraction, sample separation and concentration
US5481058A (en) 1994-01-07 1996-01-02 Minnesota Mining And Manufacturing Company Supercritical fluid extraction involving hydrofluoroalkanes
US5641510A (en) 1994-07-01 1997-06-24 Genentech, Inc. Method for treating capsules used for drug storage

Also Published As

Publication number Publication date
BR9814818A (pt) 2000-10-03
DE69836822T2 (de) 2007-04-26
CA2302276C (en) 2008-02-05
IL134731A0 (en) 2001-04-30
WO1999018939A1 (en) 1999-04-22
CZ299101B6 (cs) 2008-04-23
CY1106033T1 (el) 2011-04-06
TR200001000T2 (tr) 2000-11-21
BG65169B1 (bg) 2007-05-31
ES2281141T3 (es) 2007-09-16
AU753076B2 (en) 2002-10-10
EE200000292A (et) 2001-08-15
HUP0003990A3 (en) 2001-04-28
AU9783898A (en) 1999-05-03
PL195462B1 (pl) 2007-09-28
CN1306420A (zh) 2001-08-01
PT1024794E (pt) 2007-02-28
CA2302276A1 (en) 1999-04-22
KR20010031097A (ko) 2001-04-16
EP1024794B1 (en) 2007-01-03
WO1999018939A9 (en) 1999-06-03
JP2001519380A (ja) 2001-10-23
PL342650A1 (en) 2001-06-18
NZ504394A (en) 2002-12-20
HUP0003990A2 (en) 2001-03-28
US6228394B1 (en) 2001-05-08
EP1024794A1 (en) 2000-08-09
ATE350019T1 (de) 2007-01-15
CZ20001365A3 (cs) 2000-09-13
DE69836822D1 (de) 2007-02-15
BG104317A (en) 2000-12-29

Similar Documents

Publication Publication Date Title
DK1024794T3 (da) Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer
IS6560A (is) Lyfjasamsetning fyrir meðhöndlun á bráðum, þrálátum sársauka og/eða taugakerfissársauka og mígreni
DE69940769D1 (de) Orale flüssige zusammensetzungen
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
AP9901478A0 (en) Compounds for the treatment of ischemia.
NO972451L (no) Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
FR2791059B1 (fr) Proteine modifiee, procede de preparation de celle-ci et compositions pour une application externe contenant la proteine modifiee
AR024564A1 (es) Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico
ATE282607T1 (de) Tryptase-inhibitoren
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
IS6675A (is) Amínóalkoxýbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningar sem innihalda þær
TR200100637T2 (tr) Yeni doğal ürün türevleri
NO20033318D0 (no) 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
NO20013787D0 (no) Soyaekstrakt som inneholder lipider, fremgangsmåte for dets fremstilling og farmasöytiske og kosmetiske blandinger
EE200200694A (et) Ühendid maopõhja kahjustunud relaksatsiooni raviks, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
ATE309811T1 (de) Analgetikum aus schlangengift
NO993784L (no) Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
WO2003072053A3 (en) Compounds for treatment of copper overload
DK1017667T3 (da) 2-amino-6-methyl-7-acetyltetralin og farmaceutiske præparater til forebyggelse og terapeutisk behandling af inflammatoriske og/eller autoimmune patalogier
AU6278680A (en) Carbamates and pharmaceutical formulations containing them
AR010950A1 (es) Metodos de tratamiento de capsulas y formulaciones farmaceuticas secas y pulverizadas.